Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

An Experimental Weight-Loss Drug Cut Osteoarthritis Pain in Half for Nearly 7 in 10 Patients. The Biggest Question Remains Unanswered

Two critical phase 3 trials conducted by researchers at Northwestern University found that high doses of a new drug had an unexpected benefit.

An Experimental Weight-Loss Drug Cut Osteoarthritis Pain in Half for Nearly 7 in 10 Patients. The Biggest Question Remains Unanswered

We haven't written up this one. Inc. has the full story — the link below goes straight to it.

Read the original at inc.com →

More in Health & Medicine

More from Tuesday 10 November →